Top

Archives of Gynecology and Obstetrics

Published in:

01-09-2017 | Gynecologic Endocrinology and Reproductive Medicine

Anti-Mullerian hormone (AMH) and embryo quality assessed by time-lapse imaging (TLI): a cross-sectional observational study

Authors: P. Bhide, M. Escriba, A. Srikantharajah, H. Joshi, A. Gudi, A. Shah, G. Acharya, R. Homburg

Published in: Archives of Gynecology and Obstetrics | Issue 3/2017

Abstract

Purpose

Serum anti-Mullerian hormone shows a strong positive correlation to the quantitative ovarian reserve but its correlation to embryo quality is unclear. This study assessed the association between serum AMH as a marker of ovarian reserve and embryo quality, using the technology of time-lapse imaging of the embryos in women undergoing in vitro fertilisation (IVF) treatment.

Methods

304 embryos from 198 women undergoing IVF were included in the study. Serum AMH was assessed for all women. Embryo quality was assessed with the known implantation data (KID) score generated by the time-lapse imaging system.

Results

There was no statistically significant difference in mean serum AMH among different KID score categories (p = 0.135). This remained non-significant after controlling for confounding variables (p = 0.305).

Conclusions

The results of our study show no significant association between serum AMH and embryo quality in women undergoing IVF treatment when embryo quality was assessed using the KID scores generated by time-lapse imaging which is a better method of embryo assessment rather than conventional morphological assessment.

Nelson SM, Yates RW, Fleming R (2007) Serum anti-mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapy. Hum Reprod 22:2414–2421. doi:10.1093/humrep/dem204 CrossRefPubMed

Bhide P, Gudi A, Shah A, Timms P, Grayson K, Homburg R (2013) Anti-Müllerian hormone as a predictor of pregnancy following IVF. Reprod BioMed Online 26:247–252. doi:10.1016/j.rbmo.2012.11.018 CrossRefPubMed

Jayaprakasan K, Campbell B, Hopkisson J, Johnson I, Raine-Fenning N (2010) A prospective, comparative analysis of anti-Müllerian hormone, inhibin-b, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil Steril 93:855–864. doi:10.1016/j.fertnstert.2008.10.042 CrossRefPubMed

La Marca A, Nelson SM, Sighinolfi G, Manno M, Baraldi E, Roli L, Xella S, Marsella T, Tagliasacchi D, D’Amico R, Volpe A (2011) Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction. Reprod BioMed Online 22:341–349. doi:10.1016/j.rbmo.2010.11.005 CrossRefPubMed

Fong SL, Baart E, Martini E, Schipper I, Visser J, Themmen A, de Jong F, Fauser B, Laven J (2008) Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod BioMed Online 16:664–670. doi:10.1016/s1472-6483(10)60480-4 CrossRef

Silberstein T, MacLaughlin DT, Shai I, Trimarchi JR, Lambert-Messerlian G, Seifer DB, Keefe DL, Blazar AS (2005) Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod 21:159–163. doi:10.1093/humrep/dei270 CrossRefPubMed

Smneek J, Sweep F, Zielhuis G, Kremer J, Thomas C, Braat D (2007) Anti-Müllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril 87:223–226. doi:10.1016/j.fertnstert.2006.06.019 CrossRef

Bolton VN, Leary C, Harbottle S, Cutting R, Harper JC (2015) How should we choose the “best” embryo? A commentary on behalf of the British fertility society and the association of clinical Embryologists. Human Fertil 18:156–164. doi:10.3109/14647273.2015.1072646 CrossRef

Meseguer M, Herrero J, Tejera A, Hilligsoe KM, Ramsing NB, Remohi J (2011) The use of morphokinetics as a predictor of embryo implantation. Hum Reprod 26:2658–2671. doi:10.1093/humrep/der256 CrossRefPubMed

10.

Meseguer M, Rubio I, Cruz M, Basile N, Marcos J, Requena A (2012) Embryo incubation and selection in a time-lapse monitoring system improves pregnancy outcome compared with a standard incubator: a retrospective cohort study. Fertil Steril 98(1481–1489):e10. doi:10.1016/j.fertnstert.2012.08.016

11.

Gleicher N, Weghofer A, Barad DH (2010) Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Fertil Steril 94:2824–2827. doi:10.1016/j.fertnstert.2010.04.067 CrossRefPubMed

12.

Gomez R, Schorsch M, Hahn T, HenkeI A, Hoffmann I, Seufert R, Skala C (2016) The influence of AMH on IVF success. Arch Gynecol Obstet 293:667. doi:10.1007/s00404-015-3901-0 CrossRefPubMed

13.

Sahmay S, Demirayak G, Guralp O, Ocal P, Senturk LM, Oral E, Irez T (2012) Serum anti-Müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles. J Assist Reprod Genet 29:589–595. doi:10.1007/s10815-012-9754-6 CrossRefPubMedPubMedCentral

14.

Wang JG, Douglas NC, Nakhuda GS, Choi JM, Park SJ, Thornton MH, Guarnaccia MM, Sauer MV (2010) The association between anti-Müllerian hormone and IVF pregnancy outcomes is influenced by age. Reprod BioMed Online 21:757–761. doi:10.1016/j.rbmo.2010.06.041 CrossRefPubMed

Title: Anti-Mullerian hormone (AMH) and embryo quality assessed by time-lapse imaging (TLI): a cross-sectional observational study
Authors: P. Bhide
M. Escriba
A. Srikantharajah
H. Joshi
A. Gudi
A. Shah
G. Acharya
R. Homburg
Publication date: 01-09-2017
Publisher: Springer Berlin Heidelberg
Published in: Archives of Gynecology and Obstetrics / Issue 3/2017
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-017-4453-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Anti-Mullerian hormone (AMH) and embryo quality assessed by time-lapse imaging (TLI): a cross-sectional observational study

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2017

Outcomes of nonsurgical versus surgical treatment of cesarean scar pregnancies in the first trimester

Measurement and evaluation of fetal fat layer in the prediction of fetal macrosomia in pregnancies complicated by gestational diabetes

“Per vaginam” topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review

Down-regulation of PARP1 by miR-891b sensitizes human breast cancer cells to alkylating chemotherapeutic drugs

Prophylactic use of Bakri balloon for reduction of hemorrhage at cesarean for placenta previa: addition and clarification

Response to letter to the editor “Prophylactic use of Bakri balloon for reduction of hemorrhage at cesarean for placenta previa: addition and clarification”